vs
Priority Technology Holdings, Inc.（PRTH）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Priority Technology Holdings, Inc.的季度营收约是Tarsus Pharmaceuticals, Inc.的1.6倍（$247.1M vs $151.7M），Priority Technology Holdings, Inc.净利率更高（3.6% vs -5.5%，领先9.1%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 8.8%），Priority Technology Holdings, Inc.自由现金流更多（$30.9M vs $13.0M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 9.6%）
Priority Technology Holdings, Inc.是一家聚焦信息技术领域的企业，业务围绕计算机、通信系统等相关信息设备展开，涵盖信息的创建、处理、存储、检索与传输等相关信息技术应用服务，依托计算机科学与工程技术支撑业务开展。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
PRTH vs TARS — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $247.1M | $151.7M |
| 净利润 | $8.9M | $-8.4M |
| 毛利率 | — | — |
| 营业利润率 | 13.6% | -5.3% |
| 净利率 | 3.6% | -5.5% |
| 营收同比 | 8.8% | 128.4% |
| 净利润同比 | 23.9% | 63.8% |
| 每股收益（稀释后） | $0.10 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $247.1M | $151.7M | ||
| Q3 25 | $241.4M | $118.7M | ||
| Q2 25 | $239.8M | $102.7M | ||
| Q1 25 | $224.6M | $78.3M | ||
| Q4 24 | $227.1M | $66.4M | ||
| Q3 24 | $227.0M | $48.1M | ||
| Q2 24 | $219.9M | $40.8M | ||
| Q1 24 | $205.7M | $27.6M |
| Q4 25 | $8.9M | $-8.4M | ||
| Q3 25 | $27.6M | $-12.6M | ||
| Q2 25 | $10.9M | $-20.3M | ||
| Q1 25 | $8.3M | $-25.1M | ||
| Q4 24 | $7.2M | $-23.1M | ||
| Q3 24 | $10.6M | $-23.4M | ||
| Q2 24 | $994.0K | $-33.3M | ||
| Q1 24 | $5.2M | $-35.7M |
| Q4 25 | 13.6% | -5.3% | ||
| Q3 25 | 15.6% | -12.2% | ||
| Q2 25 | 15.6% | -21.6% | ||
| Q1 25 | 14.5% | -33.5% | ||
| Q4 24 | 15.0% | -36.8% | ||
| Q3 24 | 16.8% | -52.3% | ||
| Q2 24 | 15.1% | -81.6% | ||
| Q1 24 | 13.6% | -136.5% |
| Q4 25 | 3.6% | -5.5% | ||
| Q3 25 | 11.4% | -10.6% | ||
| Q2 25 | 4.5% | -19.8% | ||
| Q1 25 | 3.7% | -32.1% | ||
| Q4 24 | 3.2% | -34.8% | ||
| Q3 24 | 4.7% | -48.7% | ||
| Q2 24 | 0.5% | -81.6% | ||
| Q1 24 | 2.5% | -129.4% |
| Q4 25 | $0.10 | $-0.17 | ||
| Q3 25 | $0.34 | $-0.30 | ||
| Q2 25 | $0.14 | $-0.48 | ||
| Q1 25 | $0.10 | $-0.64 | ||
| Q4 24 | $-0.05 | $-0.57 | ||
| Q3 24 | $0.07 | $-0.61 | ||
| Q2 24 | $-0.23 | $-0.88 | ||
| Q1 24 | $-0.10 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.2M | $417.3M |
| 总债务越低越好 | $1.0B | $72.4M |
| 股东权益账面价值 | $-100.4M | $343.4M |
| 总资产 | $2.4B | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
| Q4 25 | $77.2M | $417.3M | ||
| Q3 25 | $57.0M | $401.8M | ||
| Q2 25 | $50.6M | $381.1M | ||
| Q1 25 | $47.6M | $407.9M | ||
| Q4 24 | $58.6M | $291.4M | ||
| Q3 24 | $41.1M | $317.0M | ||
| Q2 24 | $34.6M | $323.6M | ||
| Q1 24 | $34.3M | $298.5M |
| Q4 25 | $1.0B | $72.4M | ||
| Q3 25 | $997.5M | $72.3M | ||
| Q2 25 | $917.0M | $72.1M | ||
| Q1 25 | $918.9M | $72.0M | ||
| Q4 24 | $920.9M | $71.8M | ||
| Q3 24 | $808.1M | $71.7M | ||
| Q2 24 | $809.0M | $71.6M | ||
| Q1 24 | $631.4M | $29.9M |
| Q4 25 | $-100.4M | $343.4M | ||
| Q3 25 | $-110.3M | $335.1M | ||
| Q2 25 | $-146.1M | $332.6M | ||
| Q1 25 | $-158.3M | $342.5M | ||
| Q4 24 | $-166.8M | $224.5M | ||
| Q3 24 | $-165.8M | $237.5M | ||
| Q2 24 | $-172.1M | $252.2M | ||
| Q1 24 | $-159.9M | $275.2M |
| Q4 25 | $2.4B | $562.2M | ||
| Q3 25 | $2.2B | $534.6M | ||
| Q2 25 | $2.0B | $495.0M | ||
| Q1 25 | $1.9B | $500.8M | ||
| Q4 24 | $1.8B | $377.0M | ||
| Q3 24 | $1.8B | $376.3M | ||
| Q2 24 | $1.7B | $376.8M | ||
| Q1 24 | $1.6B | $349.3M |
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.8M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $30.9M | $13.0M |
| 自由现金流率自由现金流/营收 | 12.5% | 8.6% |
| 资本支出强度资本支出/营收 | 2.4% | 4.2% |
| 现金转化率经营现金流/净利润 | 4.12× | — |
| 过去12个月自由现金流最近4个季度 | $75.1M | $-22.3M |
8季度趋势，按日历期对齐
| Q4 25 | $36.8M | $19.3M | ||
| Q3 25 | $36.1M | $18.3M | ||
| Q2 25 | $17.1M | $-29.4M | ||
| Q1 25 | $10.0M | $-20.7M | ||
| Q4 24 | $23.8M | $-22.2M | ||
| Q3 24 | $19.8M | $-8.7M | ||
| Q2 24 | $28.7M | $-14.4M | ||
| Q1 24 | $13.3M | $-37.8M |
| Q4 25 | $30.9M | $13.0M | ||
| Q3 25 | $30.1M | $16.3M | ||
| Q2 25 | $9.2M | $-30.4M | ||
| Q1 25 | $4.9M | $-21.2M | ||
| Q4 24 | $19.1M | $-22.3M | ||
| Q3 24 | $14.5M | $-8.9M | ||
| Q2 24 | $23.6M | $-15.4M | ||
| Q1 24 | $6.7M | $-38.0M |
| Q4 25 | 12.5% | 8.6% | ||
| Q3 25 | 12.5% | 13.8% | ||
| Q2 25 | 3.8% | -29.6% | ||
| Q1 25 | 2.2% | -27.1% | ||
| Q4 24 | 8.4% | -33.5% | ||
| Q3 24 | 6.4% | -18.6% | ||
| Q2 24 | 10.7% | -37.8% | ||
| Q1 24 | 3.3% | -137.5% |
| Q4 25 | 2.4% | 4.2% | ||
| Q3 25 | 2.5% | 1.6% | ||
| Q2 25 | 3.3% | 1.0% | ||
| Q1 25 | 2.3% | 0.8% | ||
| Q4 24 | 2.0% | 0.1% | ||
| Q3 24 | 2.3% | 0.6% | ||
| Q2 24 | 2.3% | 2.5% | ||
| Q1 24 | 3.2% | 0.6% |
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 3.29× | — | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 28.87× | — | ||
| Q1 24 | 2.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
